Home Amines 25186-42-9
25186-42-9,MFCD09862609
Catalog No.:AA00BFPY

25186-42-9 | Isopropyl-(2-nitro-phenyl)-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$236.00   $166.00
- +
5g
95%
in stock  
$585.00   $410.00
- +
10g
95%
in stock  
$1,009.00   $706.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00BFPY
Chemical Name:
Isopropyl-(2-nitro-phenyl)-amine
CAS Number:
25186-42-9
Molecular Formula:
C9H12N2O2
Molecular Weight:
180.2038
MDL Number:
MFCD09862609
SMILES:
CC(Nc1ccccc1[N+](=O)[O-])C
Properties
Computed Properties
 
Complexity:
177  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
3  

Downstream Synthesis Route

[1]Schmidt,ArthurH.;Plaul,Wolfgang;Aimene,Amokrane;Hotz,Monika;Hoch,Monika[LiebigsAnnalenderChemie,1985,#5,p.1021-1035]

[1]Chen,Wen-Ching;Hsu,Yu-Chen;Lee,Ching-Yu;Yap,GlennP.A.;Ong,Tiow-Gan[Organometallics,2013,vol.32,#8,p.2435-2442]

[2]Figge,Axel;Altenbach,HansJ.;Brauer,DavidJ.;Tielmann,Patrick[TetrahedronAsymmetry,2002,vol.13,#2,p.137-144]

[3]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2006/136402,2006,A1Locationinpatent:Page/Pagecolumn82-83

[4]CurrentPatentAssignee:TEMPESTTHERAPEUTICSINC-WO2021/263079,2021,A1Locationinpatent:Paragraph00518;00519

[5]CurrentPatentAssignee:TEMPESTTHERAPEUTICSINC-WO2021/263079,2021,A1Locationinpatent:Paragraph00518;00519

[6]Hawkins,David;Lindley,JohnM.;McRobbie,IanM.;Meth-Cohn,Otto[JournaloftheChemicalSociety.PerkintransactionsI,1980,p.2387-2391]

[7]Tapia,Inés;Alonso-Cires,Luisa;López-Tudanca,PedroLuis;Mosquera,Ramón;Labeaga,Luis;Innerárity,Ana;Orjales,Aurelio[JournalofMedicinalChemistry,1999,vol.42,#15,p.2870-2880]

[8]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2011/71725,2011,A1Locationinpatent:Page/Pagecolumn68

[9]Jacobsen,E.Jon;Stelzer,LindsayS.;Belonga,KennethL.;Carter,DonaldB.;Im,WhaBin;Sethy,VimalaH.;Tang,AndrewH.;VonVoigtlander,PhilipF.;Petke,JamesD.[JournalofMedicinalChemistry,1996,vol.39,#19,p.3820-3836]

[10]DudashJr.,Joseph;Zhang,Yongzheng;Moore,JohnB.;Look,Richard;Liang,Yin;Beavers,MaryPat;Conway,BruceR.;Rybczynski,PhilipJ.;Demarest,KeithT.[BioorganicandMedicinalChemistryLetters,2005,vol.15,#21,p.4790-4793]

[11]CurrentPatentAssignee:UNIVERSALDISPLAYCORP-WO2006/56418,2006,A2Locationinpatent:Page/Pagecolumn73

[12]CurrentPatentAssignee:PFIZERINC-US2007/72918,2007,A1Locationinpatent:Page/Pagecolumn19

[13]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2007/117796,2007,A1Locationinpatent:Page/Pagecolumn15

[14]Locationinpatent:experimentalpartZhang,Puwen;Terefenko,EugeneA.;Bray,Jenifer;Deecher,Darlene;Fensome,Andrew;Harrison,Jim;Kim,Callain;Koury,Elizabeth;Mark,Lilly;McComas,CaseyC.;Mugford,CherylA.;Trybulski,EugeneJ.;Vu,AnT.;Whiteside,GarthT.;Mahaney,PaigeE.[JournalofMedicinalChemistry,2009,vol.52,#18,p.5703-5711]

[15]Locationinpatent:schemeortableBandarage,Upul;Hare,Brian;Parsons,Jonathan;Pham,Ly;Marhefka,Craig;Bemis,Guy;Tang,Qing;Moody,CameronStuver;Rodems,Steve;Shah,Sundeep;Adams,Chris;Bravo,Jose;Charonnet,Emmanuelle;Savic,Vladimir;Come,JonH.;Green,Jeremy[BioorganicandMedicinalChemistryLetters,2009,vol.19,#17,p.5191-5194]

[16]Locationinpatent:bodytextChakrabarty,Manas;Karmakar,Sulakshana;Mukherjee,Ratna;Arima,Shiho;Harigaya,Yoshihiro[MonatsheftefurChemie,2009,vol.140,#4,p.375-380]

[17]Locationinpatent:schemeortableBressi,JeromeC.;Jong,Ronde;Wu,Yiqin;Jennings,AndyJ.;Brown,JasonW.;O'Connell,Shawn;Tari,LeslieW.;Skene,RobertJ.;Vu,Phong;Navre,Marc;Cao,Xiaodong;Gangloff,AnthonyR.[BioorganicandMedicinalChemistryLetters,2010,vol.20,#10,p.3138-3141]

[18]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2006/276482,2006,A1Locationinpatent:Page/Pagecolumn19

[19]CurrentPatentAssignee:TRANSLATIONALDRUGDEVELOPMENTLLC-WO2010/151441,2010,A1Locationinpatent:Page/Pagecolumn26

[20]Locationinpatent:schemeortableKirrane,ThomasM.;Boyer,StephenJ.;Burke,Jennifer;Guo,Xin;Snow,RogerJ.;Soleymanzadeh,Lida;Swinamer,Alan;Zhang,Yunlong;Madwed,JefferyB.;Kashem,Mohammed;Kugler,Stanley;O'Neill,MargaretM.[BioorganicandMedicinalChemistryLetters,2012,vol.22,#1,p.738-742]

[21]Tronnier,Alexander;Metz,Stefan;Wagenblast,Gerhard;Muenster,Ingo;Strassner,Thomas[DaltonTransactions,2014,vol.43,#8,p.3297-3305]

[22]Zhang,Shiqi;Yi,Dong;Li,Guangxun;Li,Ling;Zhao,Gang;Tang,Zhuo[TetrahedronLetters,2021,vol.62]

[1]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2011/71725,2011,A1Locationinpatent:Page/Pagecolumn68

[2]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2006/136402,2006,A1Locationinpatent:Page/Pagecolumn82

[3]Ciambrone,Charles;Lafargue-Dit-Hauret,William;Lanoë,Pierre-Henri;Latouche,Camille;Loiseau,Frédérique;Martìnez-Vollbert,Emiliano[InorganicChemistry,2022,vol.61,#7,p.3033-3049]

[4]CurrentPatentAssignee:TEMPESTTHERAPEUTICSINC-WO2021/263079,2021,A1Locationinpatent:Paragraph00518

[5]CurrentPatentAssignee:TEMPESTTHERAPEUTICSINC-WO2021/263079,2021,A1Locationinpatent:Paragraph00518

[6]Nudelman,NormaS.;Cerdeira,Silvia[JournaloftheChemicalSociety.PerkintransactionsII,1986,p.695-698]

[7]Nudelman,NormaS.;Cerdeira,Silvia[JournaloftheChemicalSociety.PerkintransactionsII,1986,p.695-698]

[8]Nudelman,NormaS.;Cerdeira,Silvia[JournaloftheChemicalSociety.PerkintransactionsII,1986,p.695-698]

[9]DudashJr.,Joseph;Zhang,Yongzheng;Moore,JohnB.;Look,Richard;Liang,Yin;Beavers,MaryPat;Conway,BruceR.;Rybczynski,PhilipJ.;Demarest,KeithT.[BioorganicandMedicinalChemistryLetters,2005,vol.15,#21,p.4790-4793]

[10]CurrentPatentAssignee:PFIZERINC-US2007/72918,2007,A1Locationinpatent:Page/Pagecolumn19

[11]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2007/117796,2007,A1Locationinpatent:Page/Pagecolumn15

[12]Locationinpatent:schemeortableZhang,Puwen;Terefenko,EugeneA.;McComas,CaseyC.;Mahaney,PaigeE.;Vu,An;Trybulski,Eugene;Koury,Elizabeth;Johnston,Grace;Bray,Jenifer;Deecher,Darlene[BioorganicandMedicinalChemistryLetters,2008,vol.18,#23,p.6067-6070]

[13]Locationinpatent:experimentalpartZhang,Puwen;Terefenko,EugeneA.;Bray,Jenifer;Deecher,Darlene;Fensome,Andrew;Harrison,Jim;Kim,Callain;Koury,Elizabeth;Mark,Lilly;McComas,CaseyC.;Mugford,CherylA.;Trybulski,EugeneJ.;Vu,AnT.;Whiteside,GarthT.;Mahaney,PaigeE.[JournalofMedicinalChemistry,2009,vol.52,#18,p.5703-5711]

[14]Locationinpatent:schemeortableBandarage,Upul;Hare,Brian;Parsons,Jonathan;Pham,Ly;Marhefka,Craig;Bemis,Guy;Tang,Qing;Moody,CameronStuver;Rodems,Steve;Shah,Sundeep;Adams,Chris;Bravo,Jose;Charonnet,Emmanuelle;Savic,Vladimir;Come,JonH.;Green,Jeremy[BioorganicandMedicinalChemistryLetters,2009,vol.19,#17,p.5191-5194]

[15]Locationinpatent:schemeortableBressi,JeromeC.;Jong,Ronde;Wu,Yiqin;Jennings,AndyJ.;Brown,JasonW.;O'Connell,Shawn;Tari,LeslieW.;Skene,RobertJ.;Vu,Phong;Navre,Marc;Cao,Xiaodong;Gangloff,AnthonyR.[BioorganicandMedicinalChemistryLetters,2010,vol.20,#10,p.3138-3141]

[16]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2006/276482,2006,A1Locationinpatent:Page/Pagecolumn18

[17]CurrentPatentAssignee:TRANSLATIONALDRUGDEVELOPMENTLLC-WO2010/151441,2010,A1Locationinpatent:Page/Pagecolumn26

[18]Locationinpatent:schemeortableKirrane,ThomasM.;Boyer,StephenJ.;Burke,Jennifer;Guo,Xin;Snow,RogerJ.;Soleymanzadeh,Lida;Swinamer,Alan;Zhang,Yunlong;Madwed,JefferyB.;Kashem,Mohammed;Kugler,Stanley;O'Neill,MargaretM.[BioorganicandMedicinalChemistryLetters,2012,vol.22,#1,p.738-742]

[19]Zhang,Shiqi;Yi,Dong;Li,Guangxun;Li,Ling;Zhao,Gang;Tang,Zhuo[TetrahedronLetters,2021,vol.62]

[1]Figge,Axel;Altenbach,HansJ.;Brauer,DavidJ.;Tielmann,Patrick[TetrahedronAsymmetry,2002,vol.13,#2,p.137-144]

[2]CurrentPatentAssignee:UNIVERSALDISPLAYCORP-WO2006/56418,2006,A2Locationinpatent:Page/Pagecolumn72-73

[1]Reddy,T.Jagadeeswar;Leclair,Michael;Proulx,Melanie[Synlett,2005,#4,p.583-586]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:25186-42-9 Molecular Formula|25186-42-9 MDL|25186-42-9 SMILES|25186-42-9 Isopropyl-(2-nitro-phenyl)-amine